Dr Andrew Lee

Andrew Murphy, IMCS

Chief Scientific Officer



Dr. Andrew Lee is the co-founder and Chief Scientific Officer of Integrated Micro-Chromatography Systems, Inc. (IMCS), a leading supplier of recombinant enzymes and automated micro-purification technologies. After receiving his B.Sc. in Animal Physiology and Neuroscience from the University of California, San Diego in 2003, he began his scientific career in Allergan in Irvine, CA followed by research at The Scripps Research Institute in La Jolla, CA, and Seoul University in South Korea. In 2010, he earned his Ph.D. in Chemistry and Biochemistry from the University of South Carolina in Columbia, SC, where he stayed after graduation to start A&Q NanoDesigns, LLC—paving the way for the founding of IMCS in 2013.

With over 20 years of experience in analytical chemistry and biochemistry, Andrew has co-authored over 40 peer-reviewed journal articles on human embryonic stem cell culture, genetic engineering, nanomaterial design, protein and enzyme design, drugs of abuse monitoring, and automated micro-chromatography. He also holds over 10 patents on vaccine stabilization, rapid stem cell differentiation, automated micro-chromatography, and novel enzymes. He secured two NIH fast track small business grants, one under the SBIR and the other under the STTR program. These two grants were awarded to IMCS to scale manufacturing over 20 different enzymes to produce sugar-modified fatty acids, or gangliosides, a critical component of the brain and nervous system. These reagents will be provided to the general community to further research in glycolipids and the role of glycolipids in biology and medicine.

« Back